|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2900277 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13861658.6 |
| Date of filing the European patent application | 2013-07-23 | |
| (97) | Date of publication of the European application | 2015-08-05 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-16 |
| (46) | Date of publication of the claims translation | 2022-04-11 |
| (86) | Number | PCT/US2013/051667 |
| Date | 2013-07-23 |
| (87) | Number | WO 2014/092804 |
| Date | 2014-06-19 |
| (30) | Number | Date | Country code |
| 201261736684 P | 2012-12-13 | US | |
| 201361749548 P | 2013-01-07 | US |
| (72) |
GOVINDAN, Serengulam, V. , US
GOLDENBERG, David, M. , US
|
| (73) |
Immunomedics, Inc. ,
300 American Road, Morris Plains, NJ 07950,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Antikūnų ir SN-38 imunokonjugatų dozės, skirtos pagerintam veiksmingumui ir sumažintam toksiškumui |
| DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY |
| Payment date | Validity (years) | Amount | |
| 2025-06-18 | 13 | 289.00 EUR |
| 2026-07-23 |